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A spermine-dependent, polyphenylalanine-synthesizing cell-free system having an optimum activity at 
75-85°C has been developed from the extremely thermoacidophilic archaebacterium Caldariella acido- 
phila. The C. acidophila system is totally insensitive to the EF-Tu targeted antibiotics pulvomycin (at 
40°C) and kirromycin (at 47-72°C) contrary to control systems derived from both mesophilic (Escherichia 
coli) and thermoacidophilic (Bacillus acidocaldarius) eubacteria. The archaebacterial EF-Tu-equivalent 
factor is also immunologically unrelated to eubacterial EF-Tu and does not cross react with antibodies 
against Escherichia coli EF-Tu. The pulvomycin and kirromycin reactions thus provide new phyletic 
markers for archaebacterial ancestry. 
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1. INTRODUCTION 
Extant life forms are assumed to stem from the 
early divergence of a putative progenote into 3 
lines of descent [11: the eubacterial (encompassing 
most contemporary prokaryotes), the archaebac- 
terial (comprising methanogenic, halophilic and 
thermoacidophilic microorganisms), and a third 
lineage (the urkaryotic descent) destined to give 
rise to eukaryotes. While a deep phylogenetic split 
exists between the two bacterial domains [2], the 
eukaryotic cell is viewed as a phylogenetic himae- 
ra comprising both eubacterial and archaebacterial 
vestiges [2]. Indeed, two eukaryotic ribosomal pro- 
teins [3] and eukaryotic peptide translocation fac- 
tor EF 2 [4] exhibit structural similarities with their 
archaebacterial counterparts. 
activity prior to [5], or concomitant with [6], the 
ribosome requiring steps in protein synthesis. The 
extremely thermoacidophilic archaebacterium Cal- 
dariella acidophila (optimum growth temp. 87°C 
pH l-3) [7] has been investigated and compared 
to Escherichia coli and Bacillus acidocaldarius (a 
thermoacidophilic eubacterium growing optimally 
at 67°C and pH l-3) [8]. The results show that the 
archaebacterial factor functionally homologous to 
EF-Tu cannot be assigned to the EF-Tu type and 
does not share antigenic determinants with EF-Tu. 
2. MATERIALS AND METHODS 
Here, the specificity of the archaebacterial 
elongation factor equivalent to factors EF 1 (eu- 
karyotic) and EF-Tu (eubacterial) has been probed 
by using the prokaryote-specific antibiotics pul- 
vomycin [5] and kirromycin [6] which block EF-Tu 
Abbreviations: DTT, dithiothreitol; aa-tRNA, amino- 
acyl-tRNA; EF, elongation factor 
Crude ribosomes and 105 000 X g supematants 
(S-100) from C. acidophila, strain MT 4, B. acido- 
caldarius and E. coli, RNAse I;b strain, were ob- 
tained as in 191. The ribosomes were dissolved in a 
high-salt buffer (20 mM Tris-HCl (pH 7.3), 
10 mM MgO(Ac);!, 500 mM NI-L+Cl, 0.5 mM DTT) 
and purified further by centrifugation in 12 ml 
Spinco tubes for 12 h at 105 000 x g over a 7 ml 
pad of 0.5 M sucrose in high-salt buffer. Soluble S- 
100 supematant proteins were precipitated with 
70% saturated (NI-IJ~SO~, and were dissolved and 
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dialysed in 20 mM Tris-HCl (pH 7.3) 1.0 mM 
MgO(AC)z, 0.5 mM DTT, 10% glycerol. Mam- 
malian ‘run-off ribosomes and ‘pH 5 enzymes’ 
were prepared from the liver of male Albino rats 
(Wistar strain) as in [lo]; tRNA from all sources 
was isolated as in [ 111. 
Poly(U)-directed C. acidophila cell-free systems 
(125 ~1) contained (per ml): 1.0 mg ribosomes, 
2.0 mg S-100 protein, 80 PLg tRNA, 160 PLg poly(U), 
2.4 pmol ATP, 1.6 pmol GTP, 3.0 pmol spermine, 
25 pmol Tris-HCl (pH 7.3) 19 pmol MgO(Ach, 
10 pmol NI&Cl, 20 pmol D’IT, 1.2 &i of [U-14C]- 
phenylalanine (spec.act. 5 13 mCi/mmol). The 
compositions of the poly(U)-directed E. coli and B. 
acidocaldarius assay mixtures were as for C. acido- 
phi/u with the following modifications: spermine 
was omitted; N&Cl was either 70 mM (E. co/i), or 
20 mM (B. acidocaldurius); both systems contained 
creatinephosphate (10 mM) and creatinephosphate 
kinase (300 pg/ml); S-100 protein was present at 
loo-250 pg/ml. The composition of the rat liver 
poly(U)-directed cell-free system was as detailed in 
[lo]. Hot trichloroacetic acid-insoluble radioac- 
tivity was assayed as in [ 121. 
Escherichia coli EF-T and crystalline EF-Tu l 
GDP were purified as in 1161; E. coli EF-Ts was 
obtained from EF-T as in [ 131. 
3. RESULTS AND DISCUSSION 
The antibiotic sensitivity of the archaebacterial 
factor involved in aa-tRNA binding to ribosomes 
has been tested by using the poly(U)-directed C. 
acidophilu cell-free system described in section 2. 
The principal features of the thermophile system, 
illustrated kinetically in fig. 1, were as follows: 
(9 
(ii) 
(iii) 
At relatively high [Mg2+] (18-20 mM) the 
synthetic activity was obligatorily dependent 
upon spermine (2-4 mM) at both high (75 “C) 
and low (40°C) incubation temperatures. 
The spermine activation of polyphenylalanine 
synthesis is drastically counteracted by NH$ 
ions in excess of 10 mM, or by Tris-HCl 
buffer concentrations exceeding 25 mM; 
The rates of peptide-bond formation display a 
stringent Arrhenius dependence upon tem- 
perature, a stable plateau level of maximum 
activity being only attained over the 75-85°C 
temperature interval. 
Routinely the effects of pulvomycin and kir- 
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Fig.1. (a) Kinetics of polyphenylalanine synthesis by C. 
acidophila ribosomes: (e) complete assay system; (o) sys- 
tem lacking spermine incubated at either 75”C, or 40°C; 
(0) system containing 70 mM NH&l incubated at 75°C. 
(b) Arrhenius plot of incorporation velocity vs incuba- 
tion temperature. The rate constants (k) for poly- 
phenylalanine synthesis were derived from the initial 
slopes of the kinetic curves in (a); k was calculated as 
hot trichloroacetic acid-insoluble radioactivity incorpo- 
rated . min -1 . assay -1 (2.0 ,-f 260 units ribosomes). 
romycin on polyphenylalanine synthesis were as- 
sayed by using the least amount of S-100 protein 
required for optimum activity, and at either 40°C 
(pulvomycin) or 47°C (kirromycin) to rule out 
thermal degradation of the antibiotics. At 47°C the 
reference, E. coli, cell-free system was as active as 
at 37°C (not shown), while the C. acidophila sys- 
tern retained substantial activity (fig.1). The two 
antibiotics affect aa-tRNA binding to ribosomes 
by different mechanisms; pulvomycin impairs the 
ability of EF-Tu - GTP to form the ternary aa- 
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Fig.2. Effects of pulvomycin (a) and kirromycin (b) on 
the polyphenylalanine synthesizing capacities of: E. coli 
(o), B. acidoculdarius (A), C. acidophila (0) and rat liver 
(A) cell-free systems. All reactions contained 2% ethanol 
(final cont.). The control assay systems had the follow- 
ing incorporating activities (radioactivity/mg ribosome 
after 45 min incubation): E. coli 80 x lo4 cpm; B. 
acidocaldarius, 52-62 x lo4 cpm; C. acidophila, 12-20 
X 104 cpm; rat liver, 60 x 104 cpm. The incubation 
temperatures were 40°C (a) and 47°C (b). 
tRNA l EF-Tu l GTP complex [5] whereas kir- 
romycin binds stoichiometrically to EF-Tu and 
prevents its release from the ribosomal A site 161. 
The polyphenylalanine synthesizing capacities 
of the reference E. coli and B. acidocaldarius sys- 
tems are inhibited 95% and 87%, respectively, 
by pulvomycin (fig.2a) at 2.4 x 10-d M (the up- 
per solubility limit of the antibiotic in the presence 
of 2% ethanol), whereas the C. acidophila system is 
essentially unaffected; kirromycin (fig.2b) results 
Table 1 
Effect of kirromycin preheated for various time periods 
at 72°C on the polyphenylalanine synthesizing capacity 
of E. coli cell-free system 
Kirromycin Kirromycin Hot trichloroacetic acid- 
(10-A M) preincubation insoluble radioactivity 
at 72°C (min) (cpm/assay) 
Absent 58 000 
Present 0 880 
Present 4 1000 
Present 8 840 
Present 30 862 
Conditions for polyphenylalanine synthesis were as in 
section 2. Radioactivity refers to cpm in a 125 ~1 reaction 
mixture (2.0 Azm units ribosomes). Kirromycin solutions 
(10 mM) were heated in 98% (v/v) ethanol. 
in complete inhibition of the two eubacterial sys- 
tems at 2 x 1O-5 M, while C. acidophila and rat 
liver cell-free systems are left unimpaired by anti- 
biotic concentrations (10 -3 M) which completely 
inhibit EF-Tu activity in poly(U)-programmed sys- 
tems derived from kirromycin-resistant E. coli mu- 
tant strains [ 141. 
Pulvqmycin, also termed labilomycin [5], is easi- 
ly degraded at high temperature and its effect on 
the C. acidophila system was only assayed at 40°C; 
kirromycin (10 -4 M) was also tested at 72°C and 
found to be as ineffective as at 47°C (not shown). 
The lack of inhibition of the archaebacterial sys- 
tem by kirromycin at 72°C does not reflect anti- 
biotic degradation since kirromycin samples pre- 
heated to 72°C for up to 30 min are fully active 
when assayed in the E. coli cell-free system at 
37°C (table 1). 
Further evidence that the antibiotic-resistant 
archaebacterial elongation factor and eubacterial 
EF-TU are structurally distinct entities is provided 
by the experiment in fig.3 ‘in which antibodies rais- 
ed against E. coli EF-T (the 1: 1 complex of EF-Tu 
and EF-Ts) were assayed against S-100 proteins of 
E. coli, B. acidocaldarius and C. acidophila strains 
MT 4 and MT 3 (the latter is a less thermophilic 
strain growing optimally at 75°C); the precipitin 
arcs corresponding to the individual EF-Tu and 
EF-Ts components of the EF-T complex were 
identified by using E. coli crystalline EF-Tu l GDP 
257 
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Fig.3. Double-diffusion test of soluble proteins of E. 
co/i, B. acidocaldarius and C. acidophila, with antibodies 
against E. coli EF-T complex. The centre wells con- 
tained immune serum against E. coli EF-T (1.4 mg IgG 
protein). The peripheral wells contained 20 pg E. coli 
EF-Tu * GDP (Tu); 6.0 pg E. coli EF-Ts (Ts); 0.75 mg E. 
coli S-100 protein (1); 1.6 mg B. acidocaldarius S-100 
protein (2); 2.6 mg C. acidophila S-100 protein (MT-4 
strain) (3); 2.6 mg C. acidophila S-100 protein (MT-3 
strain) (4). E. coli EF-T specific immune sera were 
raised in rabbits; EF-T (0.8 mg) was given sub- 
cutaneously in complete Freund’s adjuvant. Boosters, 
(0.5 mg EF-T), were repeated 6 times over 4 months. 
The rabbits were bled 4 days after the last booster; IgG 
were precipitated with 40% saturated (NH&S04 and 
further purified by 2 cycles of precipitation with 33.3% 
saturated (NH&S04. The IgG were lastly dissolved in 
20 mM phosphate buffer, (pH 7.3) 150 mM NaCl, 45% 
glycerol and dialysed against the same solvent. 
and electrophoretically homogeneous EF-Ts as the 
reference antigens. The Ouchterlony double reac- 
tions in fig.3 show that common antigenic determi- 
nants are shared by the EF-Tu factors of such dis- 
tantly related eubacteria as E. coli and B. acidocal- 
darius; by contrast, no immunological homology 
appears to exist between eubacterial EF-Tu and 
the functionally homologous factor of either the 
MT 4 or the MT 3 strains of C. acidophila. Par- 
enthetically, the immune test also shows that in the 
eubacterial line of descent EF-Ts has been less 
stringently conserved than EF-Tu, since no anti- 
genie determinants combining with E. coli anti- 
EF-Ts antibodies are discernible among the solu- 
ble proteins of B. acidocaldarius. 
The combined evidence in fig.2 and 3 allows the 
conclusion that the archaebacterial factor involved 
in the binding of aa-tRNA to ribosomes cannot be 
assigned to the EF-Tu type. The possibility that 
the observed heterologies reflect structural adap- 
tive changes of an otherwise EF-Tu type factor to 
an unusually hot niche (rather than ancestry of the 
thermoacidophilic archaebacterial strain) can be 
discounted: 
(1) EF-Tu from the extremely thermophilic eubac- 
terium Thermus thermophilus, strain HB 8 (op- 
timum growth temp. 85’C) [16] is as sensitive 
to kirromycin as E. coli EF-Tu (Y. Kaziro, per- 
sonal communication). 
(2) Evidence has been cited [17] that a high-salt- 
dependent, EF-Tu-equivalent factor from the 
mesophilic archaebacterium Halobacterium cu- 
tirubrum is also resistant to kirromycin. 
Therefore, we feel that the pulvomycin and kir- 
romycin reactions provide new phyletic markers 
for archaebacterial ancestry. Together with pre- 
vious data on the ADP-ribosylability of the arch- 
aebacterial EF G-equivalent factor by Diphtheria 
toxin 141, these results support the notion that in 
the thermoacidophilic branch of archaebacteria 
both the aa-tRNA binding to ribosomes and the 
peptide translocation step are assisted by lineage- 
specific components. Of the 2 components 
involved, the peptide translocase is structurally 
related to that of the eukaryotic cytosol, at least in- 
sofar as it provides the prerequisite amino acid 
sequence around the modified hystidine residue 
which is ADP-ribosylated by the Diphtheria toxin 
reaction [ 181. By contrast, the relatedness of 
archaebacterial EF-Tu equivalent factor to eukary- 
otic EF-1 remains undecided; the evidence that 
both above factors lack affinity for kirromycin and 
pulvomycin does not imply per se that they are 
structurally related. To assess this point the archae- 
bacterial EF-Tu equivalent factor and eukaryotic 
EF-1 are presently being compared by peptide 
mapping and immuno-crossreactivity tests. 
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